Market cap
$99.515 M
$11.00 -0.18%
Close of 7 Aug 2026
Revenue
$26.5M
#2926 by revenue
Earnings
-$1.04M
Loss-making
Shares outstanding
9,046,799
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: In Vitro & In Vivo Diagnostic Substances — ranked by market cap
All 19 →Where these numbers come from
Share counts and financials for Immucell are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.